Inventor
UCKUN FATIH M
US100 patents
⚠️ This page may combine multiple inventors who share the name “UCKUN FATIH M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PARKER HUGHES INST
37 patentsUS6753348B2Jun 22, 2004
BTK inhibitors and methods for their identification and use
PARKER HUGHES INST130 citations99
US6313130B1Nov 6, 2001
JAK-3 inhibitors for treating allergic disorders
PARKER HUGHES INST107 citations98
US6221900B1Apr 24, 2001
BTK inhibitors and methods for their identification and use
PARKER HUGHES INST114 citations98
US6177433B1Jan 23, 2001
JAK-3 inhibitors for treating allergic disorders
PARKER HUGHES INST128 citations98
US6160010ADec 12, 2000
BTK inhibitors and methods for their identification and use
PARKER HUGHES INST190 citations98
US6080748AJun 27, 2000
Therapeutic use of JAK-3 inhibitors
PARKER HUGHES INST97 citations98
US6452005B1Sep 17, 2002
JAK-3 inhibitors for treating allergic disorders
PARKER HUGHES INST26 citations96
US6358962B2Mar 19, 2002
6,7-Dimethoxyquinazolines and therapeutic use thereof
PARKER HUGHES INST40 citations96
US6326373B1Dec 4, 2001
JAK-3 inhibitors for treating allergic disorders
PARKER HUGHES INST74 citations96
US6168932B1Jan 2, 2001
Recombinant DTctGMCSF fusion toxin in a baculovirus expression vector system
PARKER HUGHES INST139 citations96
US6495556B2Dec 17, 2002
Dimethoxy quinazolines for treating diabetes
PARKER HUGHES INST44 citations95
US6469013B2Oct 22, 2002
Therapeutic compounds
PARKER HUGHES INST51 citations95
US6303652B1Oct 16, 2001
BTK inhibitors and methods for their identification and use
PARKER HUGHES INST63 citations95
US6589992B2Jul 8, 2003
Inhibiting collagen-induced platelet aggregation
PARKER HUGHES INST20 citations93
US6503890B1Jan 7, 2003
Aryl phosphate derivatives of d4T having anti-HIV activity
PARKER HUGHES INST15 citations93
US6350736B1Feb 26, 2002
Aryl phosphate derivatives of d4T having anti-HIV activity
PARKER HUGHES INST15 citations93
US6552027B2Apr 22, 2003
Quinazolines for treating brain tumor
PARKER HUGHES INST35 citations92
US6482815B1Nov 19, 2002
Organic-arsenic compounds
PARKER HUGHES INST18 citations92
US6365626B1Apr 2, 2002
BTK inhibitors and methods for their identification and use
PARKER HUGHES INST17 citations92
US6355678B1Mar 12, 2002
Inhibitors of the EGF-receptor tyrosine kinase and methods for their use
PARKER HUGHES INST17 citations92
US6316454B1Nov 13, 2001
6,7-Dimethoxy-4-anilinoquinazolines
PARKER HUGHES INST24 citations92
US6294575B1Sep 25, 2001
BTK inhibitors and methods for their identification and use
PARKER HUGHES INST17 citations92
US6248790B1Jun 19, 2001
Treatment of inflammation with 2,4,6-trihydroxy-alpha-rho-methoxyphenylacetophenone, or its pharmaceutically acceptable derivatives
PARKER HUGHES INST40 citations92
US6191123B1Feb 20, 2001
Organic-arsenic compounds
PARKER HUGHES INST25 citations92
US7037937B2May 2, 2006
Cytotoxic compounds
PARKER HUGHES INST17 citations91
US6734207B2May 11, 2004
Cytotoxic compounds
PARKER HUGHES INST23 citations91
US6605589B1Aug 12, 2003
Cathepsin inhibitors in cancer treatment
PARKER HUGHES INST44 citations91
US6306897B1Oct 23, 2001
Calanolides for inhibiting BTK
PARKER HUGHES INST54 citations91
US6334998B1Jan 1, 2002
Estrogens for treating ALS
PARKER HUGHES INST18 citations90
US7064114B2Jun 20, 2006
Gel-microemulsion formulations
PARKER HUGHES INST50 citations88
US6262053B1Jul 17, 2001
Melamine derivatives as potent anti-cancer agents
PARKER HUGHES INST22 citations88
US6528495B1Mar 4, 2003
Aryl phosphate derivatives of d4T having anti-HIV activity
PARKER HUGHES INST9 citations82
US6251882B1Jun 26, 2001
Alkyl ketones as potent anti-cancer agents
PARKER HUGHES INST16 citations79
US7071176B2Jul 4, 2006
Aryl phosphate derivatives of AZT having anti-HIV activity
PARKER HUGHES INST4 citations74
US6670336B1Dec 30, 2003
Aryl phosphate derivatives of d4T having anti-HIV activity
PARKER HUGHES INST8 citations74
US6537975B1Mar 25, 2003
Aryl phosphate derivatives of d4T having anti-HIV activity
PARKER HUGHES INST5 citations74
US6864286B2Mar 8, 2005
Inhibitors of the EGF-receptor tyrosine kinase and methods for their use
PARKER HUGHES INST5 citations73
UNIV MINNESOTA
6 patentsUS5587459ADec 24, 1996
Immunoconjugates comprising tyrosine kinase inhibitors
UNIV MINNESOTA119 citations99
US5911995AJun 15, 1999
EGF-genistein conjugates for the treatment of cancer
UNIV MINNESOTA73 citations96
US5872223AFeb 16, 1999
Immunoconjugates comprising tyrosine kinase inhibitors
UNIV MINNESOTA83 citations96
US6689362B1Feb 10, 2004
Method for treating T-lineage leukemias and lymphomas using a CD7-specific monoclonal antibody (TXU-7) linked to the pokeweed antiviral protein (PAP)
UNIV MINNESOTA23 citations93
US6372217B1Apr 16, 2002
Methods for the treatment of CD7+ viral infection with TXU-7-PAP
UNIV MINNESOTA22 citations93
US5919457AJul 6, 1999
TXU-5/B53-PAP antiviral biotherapeutic agent for the treatment of AIDS
UNIV MINNESOTA13 citations74
HUGHES INST
3 patentsWAYNE HUGHES INST
3 patentsUS6030957AFeb 29, 2000
Aryl phosphate derivatives of d4T having anti-HIV activity
WAYNE HUGHES INST28 citations96
US6034053AMar 7, 2000
EGF-isoflavone conjugates for the prevention of restenosis
WAYNE HUGHES INST58 citations93
US6051603AApr 18, 2000
Vanadium (IV) metallocene complexes having sperm motility inhibiting activity
WAYNE HUGHES INST16 citations91
UNIV MINNESOTA AND RUTGERS
1 patentShowing the top 50 of 100 patents by PatentIndex Score.